Nutra Pharma Corp financial data

Location
12538 W. Atlantic Blvd., Coral Springs, FL
Fiscal year end
December 31
Latest financial report
Oct 16, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.77 % +40.6%
Quick Ratio 0.24 % +49.3%
Debt-to-equity -105 % -2.01%
Return On Equity -18 % +82.7%
Return On Assets 351 % -89.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.1B shares
Common Stock, Shares, Outstanding 7.04B shares -4.4%
Common Stock, Value, Issued 7.04M USD -4.4%
Weighted Average Number of Shares Outstanding, Basic 7.6B shares +3.37%
Weighted Average Number of Shares Outstanding, Diluted 7.6B shares -47.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 479K USD +435%
Operating Income (Loss) -2M USD -13.8%
Nonoperating Income (Expense) 4.57M USD -83.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.57M USD -90.1%
Net Income (Loss) Attributable to Parent 2.57M USD -90.1%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 21.7K USD -53.8%
Inventory, Net 29.1K USD -54.3%
Assets, Current 328K USD -33.9%
Property, Plant and Equipment, Net 74.6K USD -23.4%
Operating Lease, Right-of-Use Asset 233K USD +211%
Assets 725K USD -6.57%
Accounts Payable, Current 806K USD +9.36%
Employee-related Liabilities, Current 680K USD
Accrued Liabilities, Current 1.73M USD +95.2%
Contract with Customer, Liability, Current 281K USD
Liabilities, Current 13.3M USD -17.8%
Operating Lease, Liability, Noncurrent 157K USD
Liabilities 13.7M USD -17.3%
Retained Earnings (Accumulated Deficit) -74.1M USD +3.35%
Stockholders' Equity Attributable to Parent -13M USD +17.8%
Liabilities and Equity 725K USD -6.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -92.8K USD +64.1%
Net Cash Provided by (Used in) Financing Activities 82.8K USD -65%
Net Cash Provided by (Used in) Investing Activities 10K USD
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 7.04B shares -4.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 24.7K USD -3.6%
Operating Lease, Liability 234K USD +297%
Depreciation 22.8K USD +75.6%
Lessee, Operating Lease, Liability, to be Paid 262K USD +330%
Property, Plant and Equipment, Gross 130K USD -60.1%
Operating Lease, Liability, Current 77K USD +30.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 97.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 94.8K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 27.8K USD +1304%
Preferred Stock, Shares Authorized 20M shares
Operating Lease, Payments 22.7K USD
Interest Expense 4.44K USD +3.67%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares